Carlo Alberto Vignoli

Real-Life Effectiveness and Safety of Risankizumab in 131 Patients Affected by Moderate-to-Severe Plaque Psoriasis: A 52-Week Retrospective Study

Luigi Gargiulo, Luciano Ibba, Giulia Pavia et al. · Dermatology and Therapy · 2022 · 35 citations · Full text

Tralokinumab rapidly improves subjective symptoms and quality of life in patients with moderate-to-severe atopic dermatitis: a real-life 16-week experience

Luigi Gargiulo, Luciano Ibba, Carlo Alberto Vignoli et al. · Journal of Dermatological Treatment · 2023 · 21 citations · Full text

Rheumatology, Allergy, Atopic Dermatitis +8

Effectiveness and safety of baricitinib in patients with severe alopecia areata: a 36-week multicenter real-world experience

Luigi Gargiulo, Luciano Ibba, Carlo Alberto Vignoli et al. · Journal of Dermatological Treatment · 2023 · 18 citations · Full text

Clinical Dermatology, Skin Pharmacology, Pharmacotherapy +3

Safety of anti-IL-23 drugs in patients with moderate-to-severe plaque psoriasis and previous tuberculosis infection: a monocentric retrospective study

Luciano Ibba, Luigi Gargiulo, Carlo Alberto Vignoli et al. · Journal of Dermatological Treatment · 2023 · 14 citations · Full text

Autoimmune Disease, Immunology, Anti-il-23 Drugs +8

Baricitinib for the treatment of severe alopecia areata: results from a 52-week multicenter retrospective real-world study

Carlo Alberto Vignoli, Luigi Gargiulo, Luciano Ibba et al. · Journal of Dermatological Treatment · 2025 · 14 citations · Full text